Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2015
Total Assets: $337.6M
Liabilities Breakdown FY2015
Total Liabilities: $47.5M
Asset Breakdown
Total Assets: $337.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $72.1M | 21.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $11.5M | 3.4% |
| Goodwill | $9.0M | 2.7% |
| Intangible Assets | $20.8M | 6.2% |
| Other Assets | $224.3M | 66.4% |
Liabilities Breakdown
Total Liabilities: $47.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.5M | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $46.0M | 96.8% |